Royce & Associates LP Maravai Lifesciences Holdings, Inc. Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 908,778 shares of MRVI stock, worth $4.84 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
908,778
Previous 394,446
130.39%
Holding current value
$4.84 Million
Previous $2.82 Million
167.39%
% of portfolio
0.07%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding MRVI
# of Institutions
234Shares Held
140MCall Options Held
223KPut Options Held
19.4K-
Gtcr LLC20.2MShares$107 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$74.7 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$63.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$51.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$44.5 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $701M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...